The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Pathophysiology and mechanism of long COVID: a comprehensive review
Open accessAbstract
BACKGROUND: After almost 2 years of fighting against SARS-CoV-2 pandemic, the number of patients enduring persistent symptoms long after acute infection is a matter of concern. This set of symptoms was referred to as "long COVID", and it was defined more recently as "Post COVID-19 condition" by the World health Organization (WHO). Although studies have revealed that long COVID can manifest whatever the severity of inaugural illness, the underlying pathophysiology is still enigmatic. AIM: To conduct a comprehensive review to address the putative pathophysiology underlying the persisting symptoms of long COVID. METHOD: We searched 11 bibliographic databases (Cochrane Library, JBI EBP Database, Medline, Embase, PsycInfo, CINHAL, Ovid Nursing Database, Journals@Ovid, SciLit, EuropePMC, and CoronaCentral). We selected studies that put forward hypotheses on the pathophysiology, as well as those that encompassed long COVID patients in their research investigation. RESULTS: A total of 98 articles were included in the systematic review, 54 of which exclusively addressed hypotheses on pathophysiology, while 44 involved COVID patients. Studies that included patients displayed heterogeneity with respect to the severity of initial illness, timing of analysis, or presence of a control group. Although long COVID likely results from long-term organ damage due to acute-phase infection, specific mechanisms following the initial illness could contribute to the later symptoms possibly affecting many organs. As such, autonomic nervous system damage could account for many symptoms without clear evidence of organ damage. Immune dysregulation, auto-immunity, endothelial dysfunction, occult viral persistence, as well as coagulation activation are the main underlying pathophysiological mechanisms so far. CONCLUSION: Evidence on why persistent symptoms occur is still limited, and available studies are heterogeneous. Apart from long-term organ damage, many hints suggest that specific mechanisms following acute illness could be involved in long COVID symptoms. KEY MESSAGESLong-COVID is a multisystem disease that develops regardless of the initial disease severity. Its clinical spectrum comprises a wide range of symptoms.The mechanisms underlying its pathophysiology are still unclear. Although organ damage from the acute infection phase likely accounts for symptoms, specific long-lasting inflammatory mechanisms have been proposed, as well.Existing studies involving Long-COVID patients are highly heterogeneous, as they include patients with various COVID-19 severity levels and different time frame analysis, as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Attributes and predictors of long COVID
Sudre, C. H., Murray, B., Varsavsky, T., Graham, M. S., Penfold, R. S., Bowyer, R. C., Pujol, J. C., Klaser, K., Antonelli, M., Canas, L. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01292-y · Cited by 2,707 · cited 2×
“regardless of the initial disease severity [1,2].”
BackgroundClinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686 · cited 1×
“Although organ injuries developed during the acute phase can account for the long COVID symptomatology, there is now compelling evidence that patients who experienced mild or moderate forms of acute COVID-19 can still present symptoms that are unassociated with organ dysfunctions incurred during the early phase [2,6,1…”
BackgroundManagement of post-acute covid-19 in primary care
Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020) · BMJ · doi:10.1136/bmj.m3026 · Cited by 1,689
Evolution of antibody immunity to SARS-CoV-2
Gaebler, C., Wang, Z., Lorenzi, J. C. C., Muecksch, F., Finkin, S., Tokuyama, M., Cho, A., Jankovic, M., Schaefer-Babajew, D., Oliveira, T. Y., et al. (2021) · Nature · doi:10.1038/s41586-021-03207-w · Cited by 1,674
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655 · cited 2×
“Despite the possible overlap between both conditions [107,112], notable differences exist.”
BackgroundCarsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
Yong, S. J. (2021) · Infectious Diseases · doi:10.1080/23744235.2021.1924397 · Cited by 1,339 · cited 4×
“However, other authors suggested different mechanisms that were independent of the severity of acute COVID-19, three of which proposed either persisting low-grade gastrointestinal tract inflammation [32,33,44] or autonomous nerve system dysfunction [32].”
BackgroundInfluentialYeoh, Y. K., Zuo, T., Lui, G. C.-Y., Zhang, F., Liu, Q., Li, A. Y., Chung, A. C., Cheung, C. P., Tso, E. Y., Fung, K. S., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323020 · Cited by 1,317
Neuroinvasion of SARS-CoV-2 in human and mouse brain
Song, E., Zhang, C., Israelow, B., Lu-Culligan, A., Prado, A. V., Skriabine, S., Lu, P., Weizman, O.-E., Liu, F., Dai, Y., et al. (2020) · doi:10.1101/2020.06.25.169946 · Cited by 1,064
Diverse functional autoantibodies in patients with COVID-19
Wang, E. Y., Mao, T., Klein, J., Dai, Y., Huck, J. D., Jaycox, J. R., Liu, F., Zhou, T., Israelow, B., Wong, P., et al. (2021) · Nature · doi:10.1038/s41586-021-03631-y · Cited by 992
Troyer, E. A., Kohn, J. N., & Hong, S. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.04.027 · Cited by 964
The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19
Consiglio, C. R., Cotugno, N., Sardh, F., Pou, C., Amodio, D., Rodriguez, L., Tan, Z., Zicari, S., Ruggiero, A., Pascucci, G. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.016 · Cited by 919 · cited 5×
“Considering the patient level, thirteen articles supported the involvement of immune abnormalities [76,79,81,85,88,89,91,92,101–103,105,106], while one article focussed on MIS-C [97].”
BackgroundInfluentialAssociation of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases
Lindner, D., Fitzek, A., Bräuninger, H., Aleshcheva, G., Edler, C., Meissner, K., Scherschel, K., Kirchhof, P., Escher, F., Schultheiss, H.-P., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.3551 · Cited by 827
Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies
Dani, M., Dirksen, A., Taraborrelli, P., Torocastro, M., Panagopoulos, D., Sutton, R., & Lim, P. B. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-0896 · Cited by 721
Effects of COVID-19 on the Nervous System
Iadecola, C., Anrather, J., & Kamel, H. (2020) · Cell · doi:10.1016/j.cell.2020.08.028 · Cited by 667
Cerebral Micro-Structural Changes in COVID-19 Patients – An MRI-based 3-month Follow-up Study
Lu, Y., Li, X., Geng, D., Mei, N., Wu, P.-Y., Huang, C.-C., Jia, T., Zhao, Y., Wang, D., Xiao, A., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100484 · Cited by 614
Raman, B., Cassar, M. P., Tunnicliffe, E. M., Filippini, N., Griffanti, L., Alfaro-Almagro, F., Okell, T., Sheerin, F., Xie, C., Mahmod, M., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100683 · Cited by 601
Microvascular injury in the brains of patients with Covid-19
Lee, M.-H., Perl, D. P., Nair, G., Li, W., Maric, D., Murray, H., Dodd, S. J., Koretsky, A. P., Watts, J. A., Cheung, V., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2033369 · Cited by 562 · cited 1×
“In addition, two autopsy studies [67,71] provided additional support in favour of the neuroinflammation hypothesis, too.”
ResultDennis, A., Wamil, M., Alberts, J., Oben, J., Cuthbertson, D. J., Wootton, D., Crooks, M., Gabbay, M., Brady, M., Hishmeh, L., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-048391 · Cited by 560
Postmortem Examination of Patients With COVID-19
Schaller, T., Hirschbühl, K., Burkhardt, K., Braun, G., Trepel, M., Märkl, B., & Claus, R. (2020) · JAMA · doi:10.1001/jama.2020.8907 · Cited by 557 · cited 1×
“ative damage was evidenced in autopsy specimens of patients who died from COVID-19 [65,66,70] in com-”
BackgroundHeneka, M. T., Golenbock, D., Latz, E., Morgan, D., & Brown, R. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00640-3 · Cited by 555
de Melo, G. D., Lazarini, F., Levallois, S., Hautefort, C., Michel, V., Larrous, F., Verillaud, B., Aparicio, C., Wagner, S., Gheusi, G., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf8396 · Cited by 500
Musculoskeletal Consequences of COVID-19
Disser, N. P., De Micheli, A. J., Schonk, M. M., Konnaris, M. A., Piacentini, A. N., Edon, D. L., Toresdahl, B. G., Rodeo, S. A., Casey, E. K., & Mendias, C. L. (2020) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.20.00847 · Cited by 465
18F-FDG brain PET hypometabolism in patients with long COVID
Guedj, E., Campion, J. Y., Dudouet, P., Kaphan, E., Bregeon, F., Tissot-Dupont, H., Guis, S., Barthelemy, F., Habert, P., Ceccaldi, M., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05215-4 · Cited by 459
Wong, T. L., & Weitzer, D. J. (2021) · Medicina · doi:10.3390/medicina57050418 · Cited by 446
Evans, P. C., Rainger, G. E., Mason, J. C., Guzik, T. J., Osto, E., Stamataki, Z., Neil, D., Hoefer, I. E., Fragiadaki, M., Waltenberger, J., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa230 · Cited by 437
Silva Andrade, B., Siqueira, S., de Assis Soares, W. R., de Souza Rangel, F., Santos, N. O., dos Santos Freitas, A., Ribeiro da Silveira, P., Tiwari, S., Alzahrani, K. J., Góes-Neto, A., et al. (2021) · Viruses · doi:10.3390/v13040700 · Cited by 435
A Review of Persistent Post-COVID Syndrome (PPCS)
Oronsky, B., Larson, C., Hammond, T. C., Oronsky, A., Kesari, S., Lybeck, M., & Reid, T. R. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08848-3 · Cited by 422
COVID-19: from an acute to chronic disease? Potential long-term health consequences
Higgins, V., Sohaei, D., Diamandis, E. P., & Prassas, I. (2021) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1860895 · Cited by 405
Autoimmune and inflammatory diseases following COVID-19
Galeotti, C., & Bayry, J. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0448-7 · Cited by 402
Song, W.-J., Hui, C. K. M., Hull, J. H., Birring, S. S., McGarvey, L., Mazzone, S. B., & Chung, K. F. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00125-9 · Cited by 372
Wallukat, G., Hohberger, B., Wenzel, K., Fürst, J., Schulze-Rothe, S., Wallukat, A., Hönicke, A.-S., & Müller, J. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100100 · Cited by 362
Pulmonary Fibrosis in COVID-19 Survivors: Predictive Factors and Risk Reduction Strategies
Ojo, A. S., Balogun, S. A., Williams, O. T., & Ojo, O. S. (2020) · Pulmonary Medicine · doi:10.1155/2020/6175964 · Cited by 352
Østergaard, L. (2021) · Physiological Reports · doi:10.14814/phy2.14726 · Cited by 315
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
Afrin, L. B., Weinstock, L. B., & Molderings, G. J. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.09.016 · Cited by 314
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
Mitrani, R. D., Dabas, N., & Goldberger, J. J. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.06.026 · Cited by 302
Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives
Genovese, G., Moltrasio, C., Berti, E., & Marzano, A. V. (2021) · Dermatology · doi:10.1159/000512932 · Cited by 288
Najjar, S., Najjar, A., Chong, D. J., Pramanik, B. K., Kirsch, C., Kuzniecky, R. I., Pacia, S. V., & Azhar, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01896-0 · Cited by 282
Bolay, H., Gül, A., & Baykan, B. (2020) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13856 · Cited by 257
Post-viral fatigue and COVID-19: lessons from past epidemics
Islam, M. F., Cotler, J., & Jason, L. A. (2020) · Fatigue: Biomedicine, Health & Behavior · doi:10.1080/21641846.2020.1778227 · Cited by 249
Post-COVID-19 Fatigue: Potential Contributing Factors
Rudroff, T., Fietsam, A. C., Deters, J. R., Bryant, A. D., & Kamholz, J. (2020) · Brain Sciences · doi:10.3390/brainsci10121012 · Cited by 248
Qin, Y., Wu, J., Chen, T., Li, J., Zhang, G., Wu, D., Zhou, Y., Zheng, N., Cai, A., Ning, Q., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci147329 · Cited by 237
COVID-19 and chronic fatigue syndrome: Is the worst yet to come?
Wostyn, P. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110469 · Cited by 229
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review
Leung, T. Y. M., Chan, A. Y. L., Chan, E. W., Chan, V. K. Y., Chui, C. S. L., Cowling, B. J., Gao, L., Ge, M. Q., Hung, I. F. N., Ip, M. S. M., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1825914 · Cited by 226
Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis
Yong, S. J. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00793 · Cited by 226
Steardo, L., Steardo, L., & Verkhratsky, A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00949-5 · Cited by 219
Olfactory Bulb MRI and Paranasal Sinus CT Findings in Persistent COVID-19 Anosmia
Kandemirli, S. G., Altundag, A., Yildirim, D., Tekcan Sanli, D. E., & Saatci, O. (2021) · Academic Radiology · doi:10.1016/j.acra.2020.10.006 · Cited by 207
Development of ACE2 autoantibodies after SARS-CoV-2 infection
Arthur, J. M., Forrest, J. C., Boehme, K. W., Kennedy, J. L., Owens, S., Herzog, C., Liu, J., & Harville, T. O. (2021) · PLOS ONE · doi:10.1371/journal.pone.0257016 · Cited by 196
Postacute COVID-19: An Overview and Approach to Classification
Amenta, E. M., Spallone, A., Rodriguez-Barradas, M. C., El Sahly, H. M., Atmar, R. L., & Kulkarni, P. A. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa509 · Cited by 191
de Erausquin, G. A., Snyder, H., Carrillo, M., Hosseini, A. A., Brugha, T. S., Seshadri, S., & the CNS SARS‐CoV‐2 Consortium (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12255 · Cited by 191
Sun, B., Tang, N., Peluso, M. J., Iyer, N. S., Torres, L., Donatelli, J. L., Munter, S. E., Nixon, C. C., Rutishauser, R. L., Rodriguez-Barraquer, I., et al. (2021) · Cells · doi:10.3390/cells10020386 · Cited by 188
Doykov, I., Hällqvist, J., Gilmour, K. C., Grandjean, L., Mills, K. A., & Heywood, W. (2020) · F1000Research · doi:10.12688/f1000research.27287.2 · Cited by 183
Wood, E., Hall, K., & Tate, W. P. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.11.002 · Cited by 178
Sonnweber, T., Boehm, A., Sahanic, S., Pizzini, A., Aichner, M., Sonnweber, B., Kurz, K., Koppelstätter, S., Haschka, D., Petzer, V., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01546-2 · Cited by 177
Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review
Korompoki, E., Gavriatopoulou, M., Hicklen, R. S., Ntanasis-Stathopoulos, I., Kastritis, E., Fotiou, D., Stamatelopoulos, K., Terpos, E., Kotanidou, A., Hagberg, C. A., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.05.004 · Cited by 174
Blazhenets, G., Schroeter, N., Bormann, T., Thurow, J., Wagner, D., Frings, L., Weiller, C., Meyer, P. T., Dressing, A., & Hosp, J. A. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262128 · Cited by 171
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study
Sollini, M., Morbelli, S. D., Ciccarelli, M., Cecconi, M., Aghemo, A., Morelli, P., Chiola, S., Gelardi, F., & Chiti, A. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05294-3 · Cited by 166
Proposed subtypes of post‐COVID‐19 syndrome (or long‐COVID) and their respective potential therapies
Yong, S. J., & Liu, S. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2315 · Cited by 165
Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19
Dhawan, R. T., Gopalan, D., Howard, L., Vicente, A., Park, M., Manalan, K., Wallner, I., Marsden, P., Dave, S., Branley, H., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30407-0 · Cited by 163
Pulmonary fibrosis secondary to COVID-19: a narrative review
Tanni, S. E., Fabro, A. T., de Albuquerque, A., Ferreira, E. V. M., Verrastro, C. G. Y., Sawamura, M. V. Y., Ribeiro, S. M., & Baldi, B. G. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1916472 · Cited by 161
García-Abellán, J., Padilla, S., Fernández-González, M., García, J. A., Agulló, V., Andreo, M., Ruiz, S., Galiana, A., Gutiérrez, F., & Masiá, M. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01083-7 · Cited by 160
Chioh, F. W., Fong, S.-W., Young, B. E., Wu, K.-X., Siau, A., Krishnan, S., Chan, Y.-H., Carissimo, G., Teo, L. L., Gao, F., et al. (2021) · eLife · doi:10.7554/elife.64909 · Cited by 159
Alterations in T and B cell function persist in convalescent COVID-19 patients
Shuwa, H. A., Shaw, T. N., Knight, S. B., Wemyss, K., McClure, F. A., Pearmain, L., Prise, I., Jagger, C., Morgan, D. J., Khan, S., et al. (2021) · Med · doi:10.1016/j.medj.2021.03.013 · Cited by 158
Neuropsychiatric and Cognitive Sequelae of COVID-19
Kumar, S., Veldhuis, A., & Malhotra, T. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.577529 · Cited by 153
Baig, A. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00725 · Cited by 151
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145
COVID-19 and the clinical course of rheumatic manifestations
Ahmed, S., Zimba, O., & Gasparyan, A. Y. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05691-x · Cited by 140
COVID-19 symptoms over time: comparing long-haulers to ME/CFS
Jason, L. A., Islam, M. F., Conroy, K. E., Cotler, J. H., Torres, C., Johnson, M., & Mabie, B. (2021) · Fatigue Biomedicine Health & Behavior · doi:10.1080/21641846.2021.1922140 · Cited by 139
Impact of Vitamin D Deficiency on COVID-19—A Prospective Analysis from the CovILD Registry
Pizzini, A., Aichner, M., Sahanic, S., Boehm, A., Egger, A., Hoermann, G., Kurz, K., Widmann, G., Bellmann‐Weiler, R., Weiß, G., et al. (2020) · Nutrients · doi:10.3390/nu12092775 · Cited by 138
Doykov, I., Hällqvist, J., Gilmour, K. C., Grandjean, L., Mills, K. A., & Heywood, W. (2020) · F1000Research · doi:10.12688/f1000research.27287.1 · Cited by 137
Long-term sequelae following previous coronavirus epidemics
O’Sullivan, O. (2020) · Clinical Medicine · doi:10.7861/clinmed.2020-0204 · Cited by 135
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
Pérez‐Gómez, A., Vitallé, J., Gasca‐Capote, C., Gutiérrez‐Valencia, A., Trujillo‐Rodríguez, M., Serna‐Gallego, A., Muñoz‐Muela, E., Jiménez‐León, M. R., Benhnia, M. R., Rivas‐Jeremías, I., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00728-2 · Cited by 135
Stefano, G. B., Ptáček, R., Ptáčková, H., Anders, M., & Kream, R. M. (2021) · Medical Science Monitor · doi:10.12659/msm.930886 · Cited by 132
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study
Sollini, M., Ciccarelli, M., Cecconi, M., Aghemo, A., Morelli, P., Gelardi, F., & Chiti, A. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05084-3 · Cited by 130
Long COVID in the skin: a registry analysis of COVID-19 dermatological duration
McMahon, D. E., Gallman, A. E., Hruza, G. J., Rosenbach, M. A., Lipoff, J. B., Desai, S. R., French, L. E., Lim, H. W., Cyster, J. G., Fox, L. P., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30986-5 · Cited by 127
Bulfamante, G., Perrucci, G. L., Falleni, M., Sommariva, E., Tosi, D., Martinelli, C., Songia, P., Poggio, P., Carugo, S., & Pompilio, G. (2020) · Biomedicines · doi:10.3390/biomedicines8120626 · Cited by 122
Motiejūnaitė, J., Balagny, P., Arnoult, F., Mangin, L., Bancal, C., d’Ortho, M., & Frija‐Masson, J. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.614590 · Cited by 118
Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic
Attal, N., Martinez, V., & Bouhassira, D. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000884 · Cited by 114
Persistent SARS-2 infections contribute to long COVID-19
Jacobs, J. J. L. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110538 · Cited by 105
Vascular Manifestations of COVID-19 – Thromboembolism and Microvascular Dysfunction
Roberts, K. A., Colley, L. S., Agbaedeng, T. A., Ellison, G. M., & Ross, M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.598400 · Cited by 101
Forty Postmortem Examinations in COVID-19 Patients
Michele, S. D., Sun, Y., Yilmaz, M., Katsyv, I., Salvatore, M. M., Dzierba, A. L., Marboe, C. C., Brodie, D., Patel, N. M., Garcia, C. K., et al. (2020) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqaa156 · Cited by 100
Doyle, M. E., Appleton, A., Liu, Q., Yao, Q., Mazucanti, C. H., & Egan, J. M. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.05.010 · Cited by 98
Versace, V., Sebastianelli, L., Ferrazzoli, D., Romanello, R., Ortelli, P., Saltuari, L. L., D’Acunto, A., Porrazzini, F., Ajello, V., Oliviero, A., et al. (2021) · Clinical Neurophysiology · doi:10.1016/j.clinph.2021.03.001 · Cited by 95
Neurological involvement in SARS-CoV-2 infection: A clinical systematic review
Scoppettuolo, P., Borrelli, S., & Naeije, G. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100094 · Cited by 86
Managing the Inevitable Surge of Post–COVID-19 Functional Gastrointestinal Disorders
Schmulson, M. J., Ghoshal, U. C., & Barbara, G. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001062 · Cited by 84
Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection
Chun, H. J., Coutavas, E. E., Pine, A. B., Lee, A. I., Yu, V., Shallow, M., Giovacchini, C. X., Mathews, A. M., Stephenson, B., Que, L. G., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.148476 · Cited by 83
COVID-19 and the Heart: A Systematic Review of Cardiac Autopsies
Roshdy, A., Zaher, S., Fayed, H., & Coghlan, G. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.626975 · Cited by 80
Richter, A. G., Shields, A. M., Karim, A., Birch, D., Faustini, S. E., Steadman, L. G., Ward, K. E., Plant, T. D., Reynolds, G. M., Veenith, T., et al. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13623 · Cited by 78
Ogier, M., Andéol, G., Sagui, E., & Bo, G. D. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100081 · Cited by 73
Neurological Involvements of SARS-CoV2 Infection
Gasmi, A., Tippairote, T., Mujawdiya, P. K., Benahmed, A. G., Menzel, A., Dadar, M., & Bjørklund, G. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02070-6 · Cited by 71
Pain: A potential new label of COVID-19
Su, S., Cui, H., Wang, T., Shen, X., & Ma, C. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.025 · Cited by 66
Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective
Bouças, A. P., Rheinheimer, J., & Lagopoulos, J. (2020) · The Neuroscientist · doi:10.1177/1073858420967892 · Cited by 61
Buonsenso, D., Riitano, F., & Valentini, P. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00574 · Cited by 59
Krishna Murthy, P., Sivashanmugam, K., Kandasamy, M., Rajasekaran, S., & Ravikumar, V. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118883 · Cited by 56
Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
Benedetti, F., Mazza, M., Cavalli, G., Ciceri, F., Dagna, L., & Rovere-Querini, P. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09966-z · Cited by 55
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study
Savastano, M. C., Gambini, G., Cozzupoli, G. M., Crincoli, E., Savastano, A., Vico, U. D., Culiersi, C., Falsini, B., Martelli, F., Minnella, A. M., et al. (2021) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-05070-3 · Cited by 55
Azizi, S. A., & Azizi, S. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00903-7 · Cited by 54
A role for viral infections in Parkinson’s etiology?
Olsen, L. K., Dowd, E., & McKernan, D. P. (2018) · Neuronal Signaling · doi:10.1042/ns20170166 · Cited by 53
Gentile, S., Strollo, F., Mambro, A., & Ceriello, A. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14170 · Cited by 52
Xu, J., Zhou, M. L., Luo, P., Yin, Z., Wang, S., Liao, T., Yang, F., Wang, Z., Yang, D., Peng, Y., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab147 · Cited by 52
SARS-CoV-2 infection and thrombotic complications: a narrative review
Moschonas, I. C., & Tselepis, A. D. (2021) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02374-3 · Cited by 45
Thyroid sequelae of COVID-19: a systematic review of reviews
Trimboli, P., Camponovo, C., Scappaticcio, L., Bellastella, G., Piccardo, A., & Rotondi, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09653-1 · Cited by 43
Bai, Y., Xu, J., Chen, L., Fu, C., Kang, Y., Zhang, W., Fakhri, G. E., Gu, J., Shao, F., & Wang, M. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05083-4 · Cited by 40
Ren, A. L., Digby, R. J., & Needham, E. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10581-y · Cited by 35
Kazama, I. (2020) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2020.03095 · Cited by 34
COVID-19 and neurocognitive disorders
Mukaetova-Ladinska, E. B., Kronenberg, G., & Raha‐Chowdhury, R. (2020) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000687 · Cited by 33
Stang, M.-B. L., Desenclos, J., Flamant, M., Chousterman, B. G., & Tabibzadeh, N. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.613019 · Cited by 18
Prolonged Symptoms After COVID-19 Infection in Outpatients
Ramakrishnan, A., Zreloff, J., Moore, M. A., Bergquist, S. H., Cellai, M., Higdon, J., O’Keefe, J. B., Roberts, D., & Wu, H. M. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab060 · Cited by 14
A Cytokine-based model for the pathophysiology of Long COVID symptomsPreprint
Low, R. N., Low, R. J., & Akrami, A. (2020) · doi:10.31219/osf.io/7gcnv · Cited by 14
COVID-19 and the Kidneys: Risk, Damage and Sequelae
Herrera-Valdés, R., Almaguer-López, M., López-Marín, L., Bacallao-Méndez, R., Jorge, F., & Guerra-Bustillo, G. (2020) · MEDICC Review · doi:10.37757/mr2020.v22.n4.10 · Cited by 8
Cited by
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
Greenhalgh, T., Sivan, M., Perlowski, A., & Nikolich, J. Ž. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01136-x · Cited by 502
Chudzik, M., Babicki, M., Kapusta, J., Kałuzińska-Kołat, Ż., Kołat, D., Jankowski, P., & Mastalerz-Migas, A. (2022) · Viruses · doi:10.3390/v14081755 · Cited by 65
Brain-wide alterations revealed by spatial transcriptomics and proteomics in COVID-19 infection
Zhang, T., Li, Y., Pan, L., Sha, J., Bailey, M., Faure-Kumar, E., Williams, C. K., Wohlschlegel, J., Magaki, S., Niu, C., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00730-z · Cited by 20
Metadata
- Authors
- Castanares-Zapatero, D., Chalon, P., Kohn, L., Dauvrin, M., Detollenaere, J., Maertens de Noordhout, C., Primus-de Jong, C., Cleemput, I., & Van den Heede, K.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2022-05-20
- Volume
- 54
- Issue
- 1
- Pages
- 1473-1487
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W4281250656
- Cited by
- 585
- References
- 113
- FWCI
- 60.86
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.